Download Our DHN Survey Result 2024
scalehealthtech Realize your Healthcare’s Digital Transformation journey with ScaleHealthTech Learn More

3D Cell Culture Community Launched by Biotron Healthcare

Written by : Trishti Pariwal

July 16, 2023

Category Img

With the help of a distribution deal with Biotron Healthcare, Inventia is expanding internationally into the Indian market.

An Australia-based biotech company named Inventia Life Science recently unveiled a new or fresh distribution collaboration with Biotron Healthcare, a Mumbai-based company. This will help Inventia to provide its renowned RASTRUM platform to the Indian market.

Researchers can now examine and treat terrible diseases like cancer, neurological disorders, and fibrotic diseases faster, all thanks to the RASTRUM platform which is considered a game changer in cutting-edge cell model discipline. The RASTRUM platform is enabling physiologically accurate illness models through usage in biomedical research such as drug development, disease modeling, and fundamental biological research. It is a brand-new technology that was created especially for cell biology.

By carefully controlling the hydrogels and cell printing, the highly programmed system of the platform rapidly produces complicated & miniature 3D cell cultures. By changing the lengthy and laborious processes of the past, cutting-edge technology enables scientists to produce sophisticated cell models at an unparalleled rate. This allows researchers to focus more on their research and less on time-consuming optimization procedures. It is made with rapidity and simplicity at its core so that anyone, even one with no prior knowledge of bioprinting, may utilize the platform and produce useful results quickly and easily, resulting in an enhanced user-friendly experience.

'œWe can address users especially in High Throughput Screening in Pharma, CRO and related domains by taking away their challenges of spending resources in standardization. The users can thus focus on their downstream applications. Many of these users are keen and already planning to shift their assays from 2D to 3D Cell culture models. We look forward to bringing this unique and successful platform from Inventia Life Sciences to this growing 3D Cell Culture community in India in the field of Cell Biology", said Venkatesh Voleti, Director (Sales at Biotron Healthcare).


Digital Health News ( DHN) is India’s first dedicated digital health news platform launched by Industry recognized HealthTech Leaders. DHN Is Industry’s Leading Source Of HealthTech Business, Insights, Trends And Policy News.

DHN Provides In-Depth Data Analysis And Covers Most Impactful News As They Happen Across Entire Ecosystem Including Emerging Technology Trends And Innovations, Digital Health Startups, Hospitals, Health Insurance, Govt. Agencies & Policies, Pharmaceuticals And Biotech.


© Digital Health News 2024